Cencora Sees FY27 Distribution and Services Revenue Up 4%-6%
Cencora expects pharmaceutical distribution and services revenue to rise 4%-6% in FY27.
Related stories
Solstice Raises Annual Outlook on AI-Related Demand
Solstice raised its annual forecast, citing AI-related demand that drove quarterly results above expectations.
M impact | EARNINGS | Nov 04, 2026, 02:09 PM UTC
KSH International Reports September-Quarter Profit of 479.5 Million Rupees
L impact | EARNINGS | Nov 04, 2026, 02:09 PM UTC
Uniparts India Reports September-Quarter Consolidated Profit of 544.3 Million Rupees
M impact | EARNINGS | Nov 04, 2026, 02:08 PM UTC
Ellenbarrie Industrial Gases Reports September-Quarter PAT of 356.5 Million Rupees
L impact | EARNINGS | Nov 04, 2026, 02:08 PM UTC
eMudhra Reports September-Quarter Consolidated Net Profit of 327.6 Million Rupees
L impact | EARNINGS | Nov 04, 2026, 02:03 PM UTC
MGE Energy reports third-quarter EPS of $1.48
L impact | EARNINGS | Nov 04, 2026, 02:00 PM UTC